This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Kim Schenk is a panelist during the first session titled “Intellectual Property and Business Strategy.”
For more information on this event, click here.
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...
Robert Goldman, Daniel McGavock, Dr. Richard Razgaitis, and Larry Rosenberg were recognized in the latest edition of IAM Strategy 300 – The World’s Leading IP...
CRA is a proud sponsor of this event. Tim Simcoe moderates and Fei Deng speaks as a panelist during the session titled “What Next for New Madison? Current...
CRA is a proud sponsor of this event. Dan McGavock and Dan Roffman are faculty members of the conference. For more information on this event, email Sandpiper...
